Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
06/2012
06/14/2012WO2012078859A2 Protein kinase d inhibitors
06/14/2012WO2012078777A1 Bicyclic compounds as pim inhibitors
06/14/2012WO2012078608A1 Preparation of phantasmidine and analogues thereof
06/14/2012WO2012077655A1 Spiro derivative having gpr119 agonist activity
06/14/2012WO2012076942A1 4-aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof
06/14/2012WO2012076590A1 Novel triazole compounds iii
06/14/2012US20120149914 Method for Synthesizing Substituted Aminocyclohexanone Compounds
06/14/2012US20120149725 Anhydrate ot tiotropium bromide
06/14/2012US20120149703 Aza-substituted spiro derivatives
06/14/2012US20120149676 Novel compounds
06/14/2012US20120148534 Methods and compositions of treating a flaviviridae family viral infection
06/14/2012US20120145974 Chromene compound
06/14/2012CA2819373A1 Bicyclic compounds as pim inhibitors
06/14/2012CA2819277A1 Novel triazole compounds iii
06/13/2012EP2462115A1 Enzymatic transamination of cyclopamine analogs
06/13/2012CN102498115A Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
06/13/2012CN102492417A Mercury ion fluorescent probe and preparation method thereof
06/13/2012CN102491981A Amphiphilic anti-cancer drug compound modified by water-soluble vitamin E derivative, preparation, preparation method and application for compound
06/13/2012CN102491980A Oxygenated bridge multi-component and ring compound and preparation method thereof
06/13/2012CN102491979A 1-hydroxyethyl-5-substituted indolone derivative and preparation method and application thereof
06/12/2012US8198447 Fused tricyclic compound having aldose reductase inhibitory activity
06/12/2012US8198290 Methoxatin derivatives
06/12/2012US8198283 Cysteine protease inhibitors
06/12/2012CA2681962C Methods of administering epothilone analogs for the treatment of cancer
06/07/2012WO2012074757A1 Alaninyl maytansinol antibody conjugates
06/07/2012WO2012073888A1 Heteroacene compound, organic semiconductor material, and organic electronic device
06/07/2012WO2012040641A3 Compounds for treating neurodegenerative diseases
06/07/2012US20120142926 Process for Production of Camptothecin Derivative
06/07/2012US20120142911 Synthesis of ttx intermediates
06/07/2012US20120142711 Acid-labile trigger units
06/07/2012US20120138789 Phosphonium-Based Ionic Liquids and Uses
06/07/2012CA2816426A1 Alaninyl maytansinol antibody conjugates
06/06/2012EP2460796A1 Indole derivative
06/06/2012EP2460794A1 Pharmaceutical composition containing fused hetero-ring derivative
06/06/2012EP2459568A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
06/06/2012EP2459197A1 Compounds for the reduction of -amyloid production
06/06/2012CN1545508B 1,2,4-trioxolane antimalarials
06/05/2012US8193359 G-protein coupled receptor agonists
06/05/2012US8193214 Chymase inhibitors
06/05/2012US8193210 Camptothecin derivatives with antitumor activity
06/05/2012US8193208 Fused and spirocycle compounds and the use thereof
06/05/2012US8193178 Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
06/05/2012US8193120 C2-phenyl-substituted cyclic ketonols
05/2012
05/31/2012WO2012071458A1 Heterocyclic inhibitors of beta - secretase for the treatment of neurodegenerative diseases
05/31/2012WO2012071279A1 Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use
05/31/2012WO2012069917A1 Bicyclic gpr119 modulators
05/31/2012WO2012069679A1 Marine, calcium channel antagonist compounds for treating cardiovascular diseases
05/31/2012WO2012069121A1 Materials for organic electroluminescent devices
05/31/2012WO2012069008A1 3-substituted spiroheterocyclic furan and thiofuran dione derivatives useful as pesticides
05/31/2012WO2012068740A1 Methods for ultrasonication-assisted chlorination of aromatic compounds
05/31/2012US20120136153 Camptothecin analogs and methods of preparation thereof
05/31/2012US20120135982 5HT2c RECEPTOR MODULATORS
05/31/2012US20120135978 6,7-unsaturated-7-carbamoyl substituted morphinan derivative
05/31/2012US20120135885 Methods and Kits Using Extended Rhodamine Dyes
05/31/2012CA2818050A1 Bicyclic gpr119 modulators
05/30/2012EP2457915A1 Chromene compound
05/30/2012EP2457901A1 Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors
05/30/2012EP2457656A1 Catalyst precursor, method for producing the same, method for using the same, and reactor that uses the same
05/30/2012EP2456771A1 Fused aminodihydropyrimidone derivatives
05/30/2012EP1940842B1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
05/30/2012EP1771453B1 Hepatitis c inhibitor dipeptide analogs
05/30/2012CN102483572A 光聚合性组合物、滤色片及其制造方法、固体摄像元件、液晶显示装置、平版印刷版原版、以及新型化合物 An optical device, the planographic printing plate precursor, and a novel compound of the polymerizable composition, a color filter and a manufacturing method of the solid imaging device, a liquid crystal display
05/30/2012CN102482292A Modulators of 5-ht receptors and methods of use thereof
05/30/2012CN102482275A Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer
05/30/2012CN102482272A 情绪障碍治疗剂 Mood disorder therapeutic agents
05/30/2012CN102482271A 焦虑障碍治疗剂 Anxiety disorder therapeutic agents
05/30/2012CN102482257A Apoptosis signal-regulating kinase inhibitors
05/30/2012CN102482234A Nitrogen-containing compound and pharmaceutical composition
05/30/2012CN102482221A 作为katii抑制剂的双环和三环化合物 Bicyclic and tricyclic compounds as inhibitors katii
05/30/2012CN102482217A Bi - Or Tricyclic Sterically Hindered Alkoxyamines And Process For Their Preparation
05/30/2012CN102477042A 10-羟基喜树碱衍生物及其制备方法和用途 10-hydroxy camptothecin derivatives and their preparation and use
05/30/2012CN102477041A 一种盐酸千金藤素的制备方法 Preparation of a hydrochloric acid cepharanthine
05/30/2012CN102477040A Method for preparing dendrobine
05/30/2012CN102477039A 瓜馥木内酰胺碱化合物的制备方法及其在制备抗肿瘤药物中的应用 Preparation Fissistigma lactam compounds and antineoplastic base application in preparation
05/30/2012CN102002041B Phenanthroindolizidine alkaloid derivates and salt thereof as well as application of anti-cancer activity
05/30/2012CN101679449B Process for producing trans-dibenzoxenopyrrole compound and intermediate therefor
05/30/2012CN101646678B Heteroaryl derivative
05/30/2012CN101550119B Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing same
05/30/2012CN101472922B Novel benzo buprofezin derivate and application thereof as antibacterial agent
05/30/2012CN101429200B Tricyclic benzopyran compound as anti-arrhythmic agents
05/29/2012US8188095 Gyrase inhibitors and uses thereof
05/29/2012CA2512605C Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles
05/29/2012CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
05/29/2012CA2463966C Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/24/2012WO2012068234A2 Antiviral compounds
05/24/2012WO2012067425A1 Novel compound for organic electronic material and organic electroluminescent device using the same
05/24/2012WO2012066565A2 Asenapine maleate amorphous and crystalline form and process for preparation thereof
05/24/2012WO2012065963A2 Novel antiviral compounds
05/24/2012WO2011159903A3 Asenapine maleate
05/24/2012US20120129856 Compounds, compositions and methods useful for cholesterol mobilisation
05/24/2012US20120129838 Composition for Preventing and Treating Alopecia Disorder Containing Morgalanthamine Compounds as an Active Ingredient
05/24/2012US20120129833 Cyclic ketoenols for therapy
05/24/2012CA2817840A1 Antiviral compounds
05/24/2012CA2817165A1 Novel antiviral compounds
05/23/2012EP2454253A1 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/23/2012EP2454250A1 Apoptosis signal-regulating kinase inhibitors
05/23/2012EP2453870A2 Injectable formulations containing asenapine and method of treatment using same
05/23/2012EP2081919B1 Tetrahydrofuro [3, 2-b]pyrr0l-3-0ne intermediates
05/23/2012EP2046797B1 Furo [3,2-b]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors
05/23/2012CN102471347A Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 298